This site is intended for US healthcare professionals only.

BETHKIS LOGO

YouTube Email a colleague

Home/Savings & Support

Savings and support for your patients

Give your CF patients the support they need with Chiesi CareDirect®

Chiesi CareDirect is a comprehensive support program designed to help patients start, stay, and save on BETHKIS® (Tobramycin Inhalation Solution). Enroll patients in Chiesi CareDirect to help them take advantage of these valuable resources. Patients who use government-funded plans (Medicaid, Medicare Part D, etc) are not eligible for Chiesi CareDirect. See Terms and Conditions +.

Chiesi CareDirect LOGO

 

Terms and Conditions:

BETHKIS Copay Assistance Program: is available to patients with commercial insurance. Patients pay $0 out-of-pocket costs toward their BETHKIS prescription up to a monthly maximum of $1440. To obtain this benefit, patients must be enrolled in Chiesi CareDirect and utilize one of the network specialty pharmacies. Upon enrollment, the offer is valid for 12 months of copay assistance. Patients with primary enrollment in government-funded plans are not eligible for copay assistance.
 
360° Debit Card: is available to patients with commercial insurance. Patients must call 1-888-865-1222 to sign up for the 360° Debit Card. For every qualifying monthly prescription of BETHKIS that is filled, the patient can receive $50 to apply toward goods and services including nutritional foods, food services, food preparation tools, vitamins, supplements, probiotics, fitness monitoring devices, pedometers, gym memberships, and expenses related to treatment visits. This offer covers up to $150 for each 3-month supply of BETHKIS. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for the 360° Debit Card offer. Chiesi reserves the right to rescind, revoke, or amend this offer without notice at any time. This offer is good only in the U.S. The card and offer expire on 12/31/18. Patients participating in the BETHKIS Patient Assistance Program are not eligible.
 

PAP eligibility requirements:

  • Legal US resident
  • Income level within specified guidelines
  • Uninsured or underinsured:

    • Commercially insured patients without prescription coverage are eligible
    • Commercially insured patients with no plan coverage for product are eligible
    • Commercially insured patients appealing plan determination are eligible (during the appeal process)
  • Patients with a Government Funded plan are not eligible for PAP (Medicare Part D, Medicaid, etc.)
  • Commercially insured patients with high out-of-pocket costs are not considered eligible. Product is considered covered

 

$0 icon

$0 Copay Assistance Programs*

  • Patients pay as little as $0 for their copay and deductible
Free Kits icon

Free nebulizer kit and aerosol delivery system

  • Free PARI LC PLUS® nebulizer kit and Vios® Aerosol Delivery System may be available to eligible patients with a qualifying BETHKIS prescription
Phone icon

Dedicated Patient Navigator

  • Each patient is assigned to a dedicated Patient Navigator for 1-on-1 support at the start of their therapy

    • The Patient Navigator calls patients to check on their treatment and coverage
    • Adherence reports on each patient are sent to HCPs so they can better monitor treatment
Hands icon

Patient Assistance Program*

  • Available for qualified patients who are unisured or underinsured and cannot afford their medication
$50 icon

Receive up to $50 per month with the 360° Debit Card‡§

  • It is important that patients maintain a healthy lifestyle throughout treatment. They can use this credit on a variety of wellness-related items, such as:

    • Nutrition (Nutritional foods, food services, food preparation tools, vitamins, supplements, probiotics)
    • Fitness (Fitness monitoring devices, pedometers, gym membership)
    • Additonal support (Expenses related to treatment visits)
Checklist icon

Free supply with QuickStart*||

  • Patients can receive a free supply of BETHKIS

 

 

Two easy ways to enroll your patients

Fax or Email

1

Complete a Service Request Form

2

Fax: 1-866-410-6241 or
Email: Chiesicaredirect@caremetx.com

Online

Capture patient authorization signatures electronically with eHIPAA.com
If patients are not able to sign forms in the office, patients can provide their signature
from home through fax, scan, or email using eHIPAA.com

 
 

Other helpful forms

Chiesi CareDirect Patient Assistance Program Application
360° Debit Card Program Form

For more information

Contact a Chiesi CareDirect Specialist toll-free at 1-888-865-1222 from 9 am to 8 pm ET, Monday through Friday. You can also email chiesicaredirect@caremetx.com.

 

*Restrictions apply. Limit one card per person per month. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for certain components of this program. Please see full Terms and Conditions.
†Free PARI LC PLUS® nebulizer kit and Vios® Aerosol Delivery System may be available to eligible patients with a qualifying BETHKIS prescription.
‡Restrictions apply. Limit one card per person per month. Patients receive $50 per month with every BETHKIS refill (annual savings: $300). Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for certain components of this program. Please see full Terms and Conditions.
§A qualifying monthly prescription refill of BETHKIS consists of 1 treatment cycle of 28 days on/28 days off.
‖BETHKIS is shipped directly to patients and may also be available at doctor’s office.

 

Important Safety Information

BETHKIS® (Tobramycin Inhalation Solution) is contraindicated in patients with a known hypersensitivity to any aminoglycoside.

Bronchospasm can occur with inhalation of BETHKIS. Bronchospasm and wheezing should be treated as medically appropriate.

Caution should be exercised when prescribing BETHKIS to patients with known or suspected auditory, vestibular, renal, or neuromuscular dysfunction. Audiograms, serum concentration, and renal function should be monitored as appropriate.

Avoid concurrent and/or sequential use of BETHKIS with other drugs with neurotoxic or ototoxic potential.

BETHKIS should not be administered concurrently with ethacrynic acid, furosemide, urea, or mannitol.

Aminoglycosides may aggravate muscle weakness because of a potential curare-like effect on neuromuscular function.

Fetal harm can occur when aminoglycosides are administered to a pregnant woman. Apprise women of the potential hazard to the fetus.

Common adverse reactions (more than 5%) occurring more frequently in BETHKIS patients are forced expiratory volume decreased, rales, red blood cell sedimentation rate increased, and dysphonia.

Indication

BETHKIS is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of six years, patients with FEV1 less than 40% or greater than 80% predicted, or patients colonized with Burkholderia cepacia.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Please see Full Prescribing Information.

 

This website is intended for United States residents only.

Terms and Conditions

BETHKIS Copay Assistance Program is available to patients with commercial insurance. Patients pay $0 out-of-pocket costs toward their BETHKIS prescription up to a monthly maximum of $1440. To obtain this benefit, patients must be enrolled in Chiesi CareDirect and utilize one of the network specialty pharmacies. Upon enrollment, the offer is valid for 12 months of copay assistance. Patients with primary enrollment in government-funded plans are not eligible for copay assistance.

 

360° Debit Card: is available to patients with commercial insurance. Patients must call 1-888-865-1222 to sign up for the 360° Debit Card. For every qualifying monthly prescription of BETHKIS that is filled, the patient can receive $50 to apply toward goods and services including nutritional foods, food services, food preparation tools, vitamins, supplements, probiotics, fitness monitoring devices, pedometers, gym memberships, and expenses related to treatment visits. This offer covers up to $150 for each 3-month supply of BETHKIS. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for the 360° Debit Card offer. Chiesi reserves the right to rescind, revoke, or amend this offer without notice at any time. This offer is good only in the U.S. The card and offer expire on 12/31/18. Patients participating in the BETHKIS Patient Assistance Program are not eligible.

 

PAP eligibility requirements:

  • Legal US resident
  • Uninsured
  • Underinsured:
    • Commercially insured patients without prescription coverage are eligible
    • Commercially insured patients with no plan coverage for product are eligible
    • Commercially insured patients appealing plan determination are eligible (during the appeal process)
  • Patients with a Government Funded plan are not eligible for PAP (Medicare Part D, Medicaid, etc.)
  • Commercially insured patients with high out-of-pocket costs are not considered eligible. Product is considered covered

This site is intended for US healthcare professionals only.

FOR US HEALTHCARE PROFESSIONALS

I certify that I am a US healthcare professional.

YES NO

FOR PATIENTS AND CAREGIVERS

GO TO PATIENT SITE